Notices. DEPARTMENT OF JUSTICE
418 words·~2 min read·
/register/2004/06/03/04-12464A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-M DEPARTMENT OF JUSTICE Drug Enforcement Administration Importation of Controlled Substances; Notice of Application Pursuant to section 1008 of the Controlled Substances Import and Export Act (21 U.S.C. 958(i)), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I and II and prior to issuing a registration under section 10029a) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with section 1301.34 of Title 21, Code of Federal Regulations (CFR), notice is hereby given that on April 21, 2004, Research Triangle Institute, Kenneth H. Davis, Jr., Hermann Building East Institute Drive, PO Box 12194, Research Triangle Park, North Carolina 27709, made application by renewal to the Drug Enforcement Administration to be registered as an importer of the following basic classes of controlled substances: Drug Schedule Marihuana
(7360)I Cocaine
(9041)II The firm plans to import small quantities of the listed substances for the National Institute of Drug Abuse and other clients. Any manufacturer holding or applying for registration as a bulk manufacturer of these basic classes of controlled substances may file written comments on or objections to the application described above and may, at the same time, file a written request for a hearing on such application in accordance with 21 CFR 1301.43 in such form as prescribed by 21 CFR 1316.47. Any such comments, objections, or requests for a hearing may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Federal Register Representative (CCD), and must be filed no later than July 6, 2004. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice at 40 FR 43745-46 (September 23, 1975), all applications for registration to import basic classes of any controlled substances in Schedule I or II are and will continue to be required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1311.42(a), (b), (c), (d), (e), and
(f)are satisfied. Dated: May 21, 2004. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 04-12464 Filed 6-2-04; 8:45 am]
Connectionstraces to 5
1 reference not yet in our index
- 21 CFR 1311.42(a)
Citation graph
cites case law
Notices
DEPARTMENT OF JUSTICE
Cite21 CFR 1311.42(a)
Cites 6Cited by 0 across 0 sources